119 related articles for article (PubMed ID: 37474103)
21. Mitochondrial double-stranded RNA triggers antiviral signalling in humans.
Dhir A; Dhir S; Borowski LS; Jimenez L; Teitell M; Rötig A; Crow YJ; Rice GI; Duffy D; Tamby C; Nojima T; Munnich A; Schiff M; de Almeida CR; Rehwinkel J; Dziembowski A; Szczesny RJ; Proudfoot NJ
Nature; 2018 Aug; 560(7717):238-242. PubMed ID: 30046113
[TBL] [Abstract][Full Text] [Related]
22. Frame-shifted APOBEC3A encodes two alternative proapoptotic proteins that target the mitochondrial network.
Caval V; Suspène R; Khalfi P; Gaillard J; Caignard G; Vitour D; Roingeard P; Vartanian JP; Wain-Hobson S
J Biol Chem; 2021 Sep; 297(3):101081. PubMed ID: 34403699
[TBL] [Abstract][Full Text] [Related]
23. Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.
Land AM; Law EK; Carpenter MA; Lackey L; Brown WL; Harris RS
J Biol Chem; 2013 Jun; 288(24):17253-60. PubMed ID: 23640892
[TBL] [Abstract][Full Text] [Related]
24. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo.
Naumann JA; Argyris PP; Carpenter MA; Gupta HB; Chen Y; Temiz NA; Zhou Y; Durfee C; Proehl J; Koniar BL; Conticello SG; Largaespada DA; Brown WL; Aihara H; Vogel RI; Harris RS
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298259
[TBL] [Abstract][Full Text] [Related]
25. Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA.
Caval V; Suspène R; Vartanian JP; Wain-Hobson S
Mol Biol Evol; 2014 Feb; 31(2):330-40. PubMed ID: 24162735
[TBL] [Abstract][Full Text] [Related]
26. Seven-membered ring nucleobases as inhibitors of human cytidine deaminase and APOBEC3A.
Kurup HM; Kvach MV; Harjes S; Jameson GB; Harjes E; Filichev VV
Org Biomol Chem; 2023 Jun; 21(24):5117-5128. PubMed ID: 37282621
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.
Law EK; Levin-Klein R; Jarvis MC; Kim H; Argyris PP; Carpenter MA; Starrett GJ; Temiz NA; Larson LK; Durfee C; Burns MB; Vogel RI; Stavrou S; Aguilera AN; Wagner S; Largaespada DA; Starr TK; Ross SR; Harris RS
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32870257
[TBL] [Abstract][Full Text] [Related]
28. NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity.
Byeon IJ; Ahn J; Mitra M; Byeon CH; Hercík K; Hritz J; Charlton LM; Levin JG; Gronenborn AM
Nat Commun; 2013; 4():1890. PubMed ID: 23695684
[TBL] [Abstract][Full Text] [Related]
29. Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity.
Green AM; DeWeerd RA; O'Leary DR; Hansen AR; Hayer KE; Kulej K; Dineen AS; Szeto JH; Garcia BA; Weitzman MD
EMBO Rep; 2021 Sep; 22(9):e52145. PubMed ID: 34347354
[TBL] [Abstract][Full Text] [Related]
30. Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A.
Aynaud MM; Suspène R; Vidalain PO; Mussil B; Guétard D; Tangy F; Wain-Hobson S; Vartanian JP
J Biol Chem; 2012 Nov; 287(46):39182-92. PubMed ID: 22977230
[TBL] [Abstract][Full Text] [Related]
31. Murine leukemia virus resists producer cell APOBEC3A by its Glycosylated Gag but not target cell APOBEC3A.
Jaguva Vasudevan AA; Balakrishnan K; Franken A; Krikoni A; Häussinger D; Luedde T; Münk C
Virology; 2021 May; 557():1-14. PubMed ID: 33581610
[TBL] [Abstract][Full Text] [Related]
32. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
Buisson R; Lawrence MS; Benes CH; Zou L
Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
[TBL] [Abstract][Full Text] [Related]
33. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
Adolph MB; Love RP; Feng Y; Chelico L
Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
[TBL] [Abstract][Full Text] [Related]
34. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
[TBL] [Abstract][Full Text] [Related]
35. APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer.
Chen S; Li X; Qin J; Chen Y; Liu L; Zhang D; Wang M; Wang M; Zhang D
Int J Clin Exp Med; 2015; 8(7):10548-57. PubMed ID: 26379844
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.
Vieira VC; Leonard B; White EA; Starrett GJ; Temiz NA; Lorenz LD; Lee D; Soares MA; Lambert PF; Howley PM; Harris RS
mBio; 2014 Dec; 5(6):. PubMed ID: 25538195
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of antiviral innate immunity by birnavirus VP3 protein via blockage of viral double-stranded RNA binding to the host cytoplasmic RNA detector MDA5.
Ye C; Jia L; Sun Y; Hu B; Wang L; Lu X; Zhou J
J Virol; 2014 Oct; 88(19):11154-65. PubMed ID: 25031338
[TBL] [Abstract][Full Text] [Related]
38. Single-stranded DNA binding proteins influence APOBEC3A substrate preference.
Brown AL; Collins CD; Thompson S; Coxon M; Mertz TM; Roberts SA
Sci Rep; 2021 Oct; 11(1):21008. PubMed ID: 34697369
[TBL] [Abstract][Full Text] [Related]
39. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages.
Sharma S; Patnaik SK; Taggart RT; Kannisto ED; Enriquez SM; Gollnick P; Baysal BE
Nat Commun; 2015 Apr; 6():6881. PubMed ID: 25898173
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice.
Csak T; Dolganiuc A; Kodys K; Nath B; Petrasek J; Bala S; Lippai D; Szabo G
Hepatology; 2011 Jun; 53(6):1917-31. PubMed ID: 21425308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
